Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Sep;94(3):923–927. doi: 10.1172/JCI117458

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

B Dahlbäck 1
PMCID: PMC295127  PMID: 8083377

Full text

PDF
923

Images in this article

924Image
on p.924
925Image
on p.925

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allaart C. F., Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M., Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet. 1993 Jan 16;341(8838):134–138. doi: 10.1016/0140-6736(93)90003-y. [DOI] [PubMed] [Google Scholar]
  2. Bakker H. M., Tans G., Janssen-Claessen T., Thomassen M. C., Hemker H. C., Griffin J. H., Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem. 1992 Aug 15;208(1):171–178. doi: 10.1111/j.1432-1033.1992.tb17171.x. [DOI] [PubMed] [Google Scholar]
  3. Bertina R. M., Koeleman B. P., Koster T., Rosendaal F. R., Dirven R. J., de Ronde H., van der Velden P. A., Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 May 5;369(6475):64–67. doi: 10.1038/369064a0. [DOI] [PubMed] [Google Scholar]
  4. Bovill E. G., Bauer K. A., Dickerman J. D., Callas P., West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989 Feb 15;73(3):712–717. [PubMed] [Google Scholar]
  5. Dahlbäck B. Bovine coagulation factor V visualized with electron microscopy. Ultrastructure of the isolated activated forms and of the activation fragments. J Biol Chem. 1986 Jul 15;261(20):9495–9501. [PubMed] [Google Scholar]
  6. Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dahlbäck B., Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1396–1400. doi: 10.1073/pnas.91.4.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 1991 Jul 12;66(1):49–61. [PubMed] [Google Scholar]
  9. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991 Oct 29;30(43):10363–10370. doi: 10.1021/bi00107a001. [DOI] [PubMed] [Google Scholar]
  10. Esmon C. T. The protein C anticoagulant pathway. Arterioscler Thromb. 1992 Feb;12(2):135–145. doi: 10.1161/01.atv.12.2.135. [DOI] [PubMed] [Google Scholar]
  11. Faioni E. M., Franchi F., Asti D., Sacchi E., Bernardi F., Mannucci P. M. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost. 1993 Dec 20;70(6):1067–1071. [PubMed] [Google Scholar]
  12. Griffin J. H., Evatt B., Wideman C., Fernández J. A. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 1;82(7):1989–1993. [PubMed] [Google Scholar]
  13. Halbmayer W. M., Haushofer A., Schön R., Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis. 1994 Feb;5(1):51–57. doi: 10.1097/00001721-199402000-00008. [DOI] [PubMed] [Google Scholar]
  14. Heeb M. J., Mesters R. M., Tans G., Rosing J., Griffin J. H. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993 Feb 5;268(4):2872–2877. [PubMed] [Google Scholar]
  15. Heeb M. J., Rosing J., Bakker H. M., Fernandez J. A., Tans G., Griffin J. H. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2728–2732. doi: 10.1073/pnas.91.7.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Heijboer H., Brandjes D. P., Büller H. R., Sturk A., ten Cate J. W. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 1990 Nov 29;323(22):1512–1516. doi: 10.1056/NEJM199011293232202. [DOI] [PubMed] [Google Scholar]
  17. Kane W. H., Davie E. W. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood. 1988 Mar;71(3):539–555. [PubMed] [Google Scholar]
  18. Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993 Dec 18;342(8886-8887):1503–1506. doi: 10.1016/s0140-6736(05)80081-9. [DOI] [PubMed] [Google Scholar]
  19. Krishnaswamy S., Williams E. B., Mann K. G. The binding of activated protein C to factors V and Va. J Biol Chem. 1986 Jul 25;261(21):9684–9693. [PubMed] [Google Scholar]
  20. Lindblad B., Svensson P. J., Dahlbäck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet. 1994 Apr 9;343(8902):917–917. doi: 10.1016/s0140-6736(94)90035-3. [DOI] [PubMed] [Google Scholar]
  21. Malm J., Laurell M., Nilsson I. M., Dahlbäck B. Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost. 1992 Jul 6;68(1):7–13. [PubMed] [Google Scholar]
  22. Mesters R. M., Heeb M. J., Griffin J. H. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry. 1993 Nov 30;32(47):12656–12663. doi: 10.1021/bi00210a014. [DOI] [PubMed] [Google Scholar]
  23. Miletich J. P., Prescott S. M., White R., Majerus P. W., Bovill E. G. Inherited predisposition to thrombosis. Cell. 1993 Feb 26;72(4):477–480. doi: 10.1016/0092-8674(93)90063-v. [DOI] [PubMed] [Google Scholar]
  24. Miletich J., Sherman L., Broze G., Jr Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987 Oct 15;317(16):991–996. doi: 10.1056/NEJM198710153171604. [DOI] [PubMed] [Google Scholar]
  25. Odegaard B., Mann K. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem. 1987 Aug 15;262(23):11233–11238. [PubMed] [Google Scholar]
  26. Salem H. H., Esmon N. L., Esmon C. T., Majerus P. W. Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro. J Clin Invest. 1984 Apr;73(4):968–972. doi: 10.1172/JCI111321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shen L., Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994 Jul 22;269(29):18735–18738. [PubMed] [Google Scholar]
  28. Suzuki K., Stenflo J., Dahlbäck B., Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem. 1983 Feb 10;258(3):1914–1920. [PubMed] [Google Scholar]
  29. Svensson P. J., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994 Feb 24;330(8):517–522. doi: 10.1056/NEJM199402243300801. [DOI] [PubMed] [Google Scholar]
  30. Tabernero M. D., Tomas J. F., Alberca I., Orfao A., Lopez Borrasca A., Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol. 1991 Apr;36(4):249–254. doi: 10.1002/ajh.2830360405. [DOI] [PubMed] [Google Scholar]
  31. Walker F. J. Identification of a new protein involved in the regulation of the anticoagulant activity of activated protein C. Protein S-binding protein. J Biol Chem. 1986 Aug 15;261(23):10941–10944. [PubMed] [Google Scholar]
  32. Walker F. J., Scandella D., Fay P. J. Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem. 1990 Jan 25;265(3):1484–1489. [PubMed] [Google Scholar]
  33. Zöller B., Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994 Jun 18;343(8912):1536–1538. doi: 10.1016/s0140-6736(94)92940-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES